Annual EBIT
-$30.03 M
+$9.72 M+24.46%
31 December 2023
Summary:
NRx Pharmaceuticals annual earnings before interest & taxes is currently -$30.03 million, with the most recent change of +$9.72 million (+24.46%) on 31 December 2023. During the last 3 years, it has risen by +$21.69 million (+41.94%). NRXPW annual EBIT is now -6195.82% below its all-time high of $492.63 thousand, reached on 31 December 2019.NRXPW EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$1.62 M
+$6.27 M+79.45%
30 September 2024
Summary:
NRx Pharmaceuticals quarterly earnings before interest & taxes is currently -$1.62 million, with the most recent change of +$6.27 million (+79.45%) on 30 September 2024. Over the past year, it has increased by +$4.40 million (+73.05%). NRXPW quarterly EBIT is now -100.01% below its all-time high of $20.43 billion, reached on 31 December 2021.NRXPW Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$20.07 M
+$4.40 M+17.98%
30 September 2024
Summary:
NRx Pharmaceuticals TTM earnings before interest & taxes is currently -$20.07 million, with the most recent change of +$4.40 million (+17.98%) on 30 September 2024. Over the past year, it has dropped by -$14.05 million (-233.28%). NRXPW TTM EBIT is now -100.10% below its all-time high of $20.39 billion, reached on 30 June 2022.NRXPW TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NRXPW EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.5% | +73.0% | -233.3% |
| 3 y3 years | +41.9% | +92.2% | +67.8% |
| 5 y5 years | - | -2266.0% | -4025.2% |
NRXPW EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +67.7% | -100.0% | +92.2% | -100.1% | +67.8% |
| 5 y | 5 years | -6195.8% | +67.7% | -100.0% | +93.6% | -100.1% | +67.8% |
| alltime | all time | -6195.8% | +67.7% | -100.0% | +93.6% | -100.1% | +67.8% |
NRx Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.62 M(-79.4%) | -$20.07 M(-18.0%) |
| June 2024 | - | -$7.90 M(+25.4%) | -$24.47 M(+47.7%) |
| Mar 2024 | - | -$6.30 M(+48.1%) | -$16.57 M(+61.3%) |
| Dec 2023 | -$30.03 M(-24.5%) | -$4.25 M(-29.4%) | -$10.27 M(+70.6%) |
| Sept 2023 | - | -$6.02 M(-13.7%) | -$6.02 M(-100.0%) |
| Dec 2022 | -$39.75 M(-57.3%) | - | - |
| June 2022 | - | -$6.98 M(-48.1%) | $20.39 B(+0.0%) |
| Mar 2022 | - | -$13.45 M(-100.1%) | $20.38 B(+0.1%) |
| Dec 2021 | -$93.05 M | $20.43 B(<-9900.0%) | $20.37 B(<-9900.0%) |
| Sept 2021 | - | -$20.77 M(+29.8%) | -$62.26 M(+33.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$16.00 M(-37.2%) | -$46.64 M(+52.8%) |
| Mar 2021 | - | -$25.48 M(>+9900.0%) | -$30.53 M(+549.7%) |
| Dec 2020 | -$51.72 M(<-9900.0%) | -$416.57(-100.0%) | -$4.70 M(-0.4%) |
| Sept 2020 | - | -$5.15 M(-5012.5%) | -$4.72 M(-1030.6%) |
| June 2020 | - | $104.82 K(-69.7%) | $506.92 K(-18.1%) |
| Mar 2020 | - | $345.85 K(-1951.8%) | $618.80 K(+25.6%) |
| Dec 2019 | $492.63 K | -$18.68 K(-124.9%) | $492.63 K(-3.7%) |
| Sept 2019 | - | $74.93 K(-65.4%) | $511.31 K(+17.2%) |
| June 2019 | - | $216.70 K(-1.4%) | $436.38 K(+98.6%) |
| Mar 2019 | - | $219.68 K | $219.68 K |
FAQ
- What is NRx Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual EBIT year-on-year change?
- What is NRx Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly EBIT year-on-year change?
- What is NRx Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals TTM EBIT year-on-year change?
What is NRx Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of NRXPW is -$30.03 M
What is the all time high annual EBIT for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual earnings before interest & taxes is $492.63 K
What is NRx Pharmaceuticals annual EBIT year-on-year change?
Over the past year, NRXPW annual earnings before interest & taxes has changed by +$9.72 M (+24.46%)
What is NRx Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of NRXPW is -$1.62 M
What is the all time high quarterly EBIT for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly earnings before interest & taxes is $20.43 B
What is NRx Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, NRXPW quarterly earnings before interest & taxes has changed by +$4.40 M (+73.05%)
What is NRx Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of NRXPW is -$20.07 M
What is the all time high TTM EBIT for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high TTM earnings before interest & taxes is $20.39 B
What is NRx Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, NRXPW TTM earnings before interest & taxes has changed by -$14.05 M (-233.28%)